ATE124935T1 - 2-aminopyrimidin-4-carboxamidderivate, ihre herstellung und verwendung als heilmittel. - Google Patents
2-aminopyrimidin-4-carboxamidderivate, ihre herstellung und verwendung als heilmittel.Info
- Publication number
- ATE124935T1 ATE124935T1 AT92401773T AT92401773T ATE124935T1 AT E124935 T1 ATE124935 T1 AT E124935T1 AT 92401773 T AT92401773 T AT 92401773T AT 92401773 T AT92401773 T AT 92401773T AT E124935 T1 ATE124935 T1 AT E124935T1
- Authority
- AT
- Austria
- Prior art keywords
- aminopyrimidine
- preparation
- medicinal products
- carboxamide derivatives
- ethyl
- Prior art date
Links
- ASFQWXQESJPZFG-UHFFFAOYSA-N 2-aminopyrimidine-4-carboxamide Chemical class NC(=O)C1=CC=NC(N)=N1 ASFQWXQESJPZFG-UHFFFAOYSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- -1 dimethoxyalkyl Chemical group 0.000 abstract 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9107939A FR2678272B1 (fr) | 1991-06-27 | 1991-06-27 | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE124935T1 true ATE124935T1 (de) | 1995-07-15 |
Family
ID=9414359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92401773T ATE124935T1 (de) | 1991-06-27 | 1992-06-24 | 2-aminopyrimidin-4-carboxamidderivate, ihre herstellung und verwendung als heilmittel. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5244894A (de) |
| EP (1) | EP0520883B1 (de) |
| JP (1) | JP3159526B2 (de) |
| KR (1) | KR930000508A (de) |
| CN (1) | CN1067885A (de) |
| AT (1) | ATE124935T1 (de) |
| AU (1) | AU644295B2 (de) |
| CA (1) | CA2072433A1 (de) |
| CZ (1) | CZ9202003A3 (de) |
| DE (1) | DE69203402T2 (de) |
| DK (1) | DK0520883T3 (de) |
| ES (1) | ES2077998T3 (de) |
| FI (1) | FI922982L (de) |
| FR (1) | FR2678272B1 (de) |
| GR (1) | GR3017249T3 (de) |
| HU (1) | HUT61749A (de) |
| IE (1) | IE922094A1 (de) |
| IL (1) | IL102332A0 (de) |
| MX (1) | MX9203333A (de) |
| NO (1) | NO922525L (de) |
| NZ (1) | NZ243340A (de) |
| PL (1) | PL295045A1 (de) |
| ZA (1) | ZA924785B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69232825D1 (de) * | 1991-08-14 | 2002-11-21 | Procter & Gamble Pharma | Zyklische Harnstoffe mit antiarrhythmischer und antifibrillatorischer Wirkung |
| ATE123025T1 (de) * | 1992-07-03 | 1995-06-15 | Synthelabo | 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica. |
| FR2703355B1 (fr) * | 1993-03-29 | 1995-05-05 | Synthelabo | Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique. |
| DE4425143A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
| US5688795A (en) * | 1994-11-08 | 1997-11-18 | Syntex (U.S.A.) Inc. | 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists |
| FR2744722B1 (fr) * | 1996-02-14 | 1998-03-13 | Synthelabo | Devires de 2-((3-(piperazin-1-yl)propyl)amino)pyrimidine-4- carboxamide et leur application en therapeutique |
| MXPA00010805A (es) | 1998-05-06 | 2002-05-08 | Univ Duke | Metodo para el tratamiento de sindromes de la vejiga y del tracto urinario inferior. |
| US7064211B2 (en) * | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
| US8071624B2 (en) | 2004-06-24 | 2011-12-06 | Incyte Corporation | N-substituted piperidines and their use as pharmaceuticals |
| WO2006002350A1 (en) * | 2004-06-24 | 2006-01-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| CA2584502A1 (en) | 2004-06-24 | 2006-01-05 | Incyte Corporation | 2-methylpropanamides and their use as pharmaceuticals |
| CA2571258A1 (en) * | 2004-06-24 | 2006-01-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| AU2005273986A1 (en) * | 2004-08-10 | 2006-02-23 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| JP6345651B2 (ja) * | 2012-05-09 | 2018-06-20 | サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | ヘテロアリール化合物及びその使用方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2143730A1 (de) * | 1971-09-01 | 1973-03-08 | Byk Gulden Lomberg Chem Fab | Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel |
| FR2656609B1 (fr) * | 1989-12-28 | 1992-03-27 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
| FR2678271B1 (fr) * | 1991-06-27 | 1995-01-13 | Synthelabo | Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
-
1991
- 1991-06-27 FR FR9107939A patent/FR2678272B1/fr not_active Expired - Fee Related
-
1992
- 1992-06-24 DK DK92401773.4T patent/DK0520883T3/da active
- 1992-06-24 ES ES92401773T patent/ES2077998T3/es not_active Expired - Lifetime
- 1992-06-24 EP EP92401773A patent/EP0520883B1/de not_active Expired - Lifetime
- 1992-06-24 DE DE69203402T patent/DE69203402T2/de not_active Expired - Fee Related
- 1992-06-24 AT AT92401773T patent/ATE124935T1/de not_active IP Right Cessation
- 1992-06-25 MX MX9203333A patent/MX9203333A/es unknown
- 1992-06-26 NO NO92922525A patent/NO922525L/no unknown
- 1992-06-26 NZ NZ243340A patent/NZ243340A/en unknown
- 1992-06-26 CN CN92105057A patent/CN1067885A/zh active Pending
- 1992-06-26 KR KR1019920011216A patent/KR930000508A/ko not_active Withdrawn
- 1992-06-26 ZA ZA924785A patent/ZA924785B/xx unknown
- 1992-06-26 FI FI922982A patent/FI922982L/fi unknown
- 1992-06-26 CA CA002072433A patent/CA2072433A1/en not_active Abandoned
- 1992-06-26 JP JP16907392A patent/JP3159526B2/ja not_active Expired - Fee Related
- 1992-06-26 AU AU18588/92A patent/AU644295B2/en not_active Ceased
- 1992-06-26 HU HU9202143A patent/HUT61749A/hu unknown
- 1992-06-26 IL IL102332A patent/IL102332A0/xx unknown
- 1992-06-26 US US07/904,060 patent/US5244894A/en not_active Expired - Fee Related
- 1992-06-26 PL PL29504592A patent/PL295045A1/xx unknown
- 1992-06-26 CZ CS922003A patent/CZ9202003A3/cs unknown
- 1992-07-01 IE IE209492A patent/IE922094A1/en not_active Application Discontinuation
-
1995
- 1995-08-30 GR GR950402360T patent/GR3017249T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1858892A (en) | 1993-01-07 |
| US5244894A (en) | 1993-09-14 |
| CZ9202003A3 (en) | 1993-01-13 |
| FR2678272B1 (fr) | 1994-01-14 |
| KR930000508A (ko) | 1993-01-15 |
| NZ243340A (en) | 1994-02-25 |
| EP0520883B1 (de) | 1995-07-12 |
| PL295045A1 (en) | 1993-03-08 |
| FI922982A0 (fi) | 1992-06-26 |
| CA2072433A1 (en) | 1992-12-28 |
| DK0520883T3 (da) | 1995-12-11 |
| NO922525D0 (no) | 1992-06-26 |
| FI922982A7 (fi) | 1992-12-28 |
| CN1067885A (zh) | 1993-01-13 |
| IE922094A1 (en) | 1992-12-30 |
| ZA924785B (en) | 1993-03-31 |
| FI922982L (fi) | 1992-12-28 |
| DE69203402T2 (de) | 1996-03-07 |
| HU9202143D0 (en) | 1992-10-28 |
| ES2077998T3 (es) | 1995-12-01 |
| EP0520883A1 (de) | 1992-12-30 |
| IL102332A0 (en) | 1993-01-14 |
| JPH05186435A (ja) | 1993-07-27 |
| JP3159526B2 (ja) | 2001-04-23 |
| AU644295B2 (en) | 1993-12-02 |
| GR3017249T3 (en) | 1995-11-30 |
| MX9203333A (es) | 1993-02-01 |
| NO922525L (no) | 1992-12-28 |
| FR2678272A1 (fr) | 1992-12-31 |
| HUT61749A (en) | 1993-03-01 |
| DE69203402D1 (de) | 1995-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE124935T1 (de) | 2-aminopyrimidin-4-carboxamidderivate, ihre herstellung und verwendung als heilmittel. | |
| FI980175L (fi) | 2-sulfonamidofenonijohdannaisia | |
| IL66650A (en) | Dibenzoxepines and dibenzooxazepines,their preparation and pharmaceutical compositions containing them | |
| HU9503930D0 (en) | Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents | |
| NO180166C (no) | Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene | |
| DE69208955D1 (de) | Pyrimidin-4-carboxamidderivate, ihre Herstellung und ihre Verwendung in der Therapie | |
| ATE40358T1 (de) | 2,3-dihydrobenzofuran-derivate, mehrere verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
| DE68903680D1 (de) | 6-phenyl-3-piperazinylalkyl-1h,3h-pyrimidindion-2,4-derivate, deren herstellung und verwendung als heilmittel. | |
| DE69410509D1 (de) | Benzoxazinderivate, deren Herstellung und deren Verwendung in Therapie | |
| DK326481A (da) | Fremgangsmaade til fremstilling af i 5-stillingen substituerede 5,10-dihydro-11h-dibenzo (b,e) (1,4) diazepin-11-oner eller syreadditionssalte deraf | |
| ATE123025T1 (de) | 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica. | |
| SE8005493L (sv) | 4-(haftalenyloxi)piperidin-derivat | |
| DE3862660D1 (de) | 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel. | |
| ATE28192T1 (de) | 4-alkylimidazol-derivate, ihre herstellung und verwendung. | |
| ATE33134T1 (de) | 2-aminoethyl-pyridin oder pyrazin-derivate, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE68906827D1 (de) | Phenothiazinderivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE134607T1 (de) | Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung | |
| ATE106080T1 (de) | Sulfonylindolizinderivate, verfahren zu ihrer herstellung und ihre verwendung als synthese- zwischenprodukte. | |
| AU537086B2 (en) | 4-amino-2,6-diaryl-tetrahydrothiopyrans | |
| ATE53839T1 (de) | 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| DE69420179D1 (de) | 2-Aminopyrazin-5-carbonsäureamid Derivate, deren Herstellung und deren Verwendung als Heilmittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |